share_log

Cassava Sciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Remi Barbier(5.7%)

Cassava Sciences | SC 13G/A:超过5%持股股东披露文件(修正)-Remi Barbier(5.7%)

SEC announcement ·  02/01 16:03
Moomoo AI 已提取核心信息
Cassava Sciences, Inc., a biotechnology company, has filed an amended Schedule 13G/A with the U.S. Securities and Exchange Commission (SEC) on February 1, 2024. The filing indicates that Remi Barbier, President, CEO, and Chairman of Cassava Sciences, beneficially owns 2,488,531 shares of the company's common stock, representing 5.7% of the class. The document details that Barbier has sole voting and dispositive power over 1,778,465 shares and shared voting and dispositive power over 710,066 shares. The filing, dated December 31, 2023, is a routine disclosure that specifies the ownership percentage and voting rights of significant shareholders. It also includes a certification by Barbier, stating that the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.
Cassava Sciences, Inc., a biotechnology company, has filed an amended Schedule 13G/A with the U.S. Securities and Exchange Commission (SEC) on February 1, 2024. The filing indicates that Remi Barbier, President, CEO, and Chairman of Cassava Sciences, beneficially owns 2,488,531 shares of the company's common stock, representing 5.7% of the class. The document details that Barbier has sole voting and dispositive power over 1,778,465 shares and shared voting and dispositive power over 710,066 shares. The filing, dated December 31, 2023, is a routine disclosure that specifies the ownership percentage and voting rights of significant shareholders. It also includes a certification by Barbier, stating that the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.
生物技术公司木薯科学公司已于2024年2月1日向美国证券交易委员会(SEC)提交了经修订的附表13G/A。该文件显示,木薯科学总裁、首席执行官兼董事长雷米·巴比尔实益拥有该公司普通股的2,488,531股,占该类别的5.7%。该文件详细说明,巴比尔对1,778,465股股票拥有唯一的投票权和处置权,对710,066股股票拥有共同的投票权和处置权。该文件日期为2023年12月31日,是一份例行披露,具体说明了大股东的所有权百分比和投票权。它还包括Barbier的认证,该证明表明这些股票是在正常业务过程中收购的,不是为了改变或影响发行人的控制权。
生物技术公司木薯科学公司已于2024年2月1日向美国证券交易委员会(SEC)提交了经修订的附表13G/A。该文件显示,木薯科学总裁、首席执行官兼董事长雷米·巴比尔实益拥有该公司普通股的2,488,531股,占该类别的5.7%。该文件详细说明,巴比尔对1,778,465股股票拥有唯一的投票权和处置权,对710,066股股票拥有共同的投票权和处置权。该文件日期为2023年12月31日,是一份例行披露,具体说明了大股东的所有权百分比和投票权。它还包括Barbier的认证,该证明表明这些股票是在正常业务过程中收购的,不是为了改变或影响发行人的控制权。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息